Mark Kris, MD, William and Joy Ruane Chair in Thoracic Oncology, Memorial Sloan Kettering Cancer Center, discusses the benefits of new therapies for lung cancer.Â
Karen Lee, NP, explains the importance of keeping patients with cancer hopeful but realistic when starting immunotherapies.
Joanne McGovern, MSN, RN, CCRN, offers some tips on how to encourage nurses to create and implement their own research projects.
Oncology nurses at local and specialized centers can work together to create a pathway for patients throughout CAR T-cell therapy treatment.
Genetic testing can be very beneficial to patients and their families. However, some people are still unsure about having it done.
Nina Grenon, RN, APRN, BC, nurse practitioner, Dana-Farber Cancer Institute, discusses the results of a study that looked at the effect of palliative care in patients with lung cancer.
Penny Daugherty, RN, MSN, OCN, of Northside Hospital Cancer Institute, discusses the harmful and confusing misinformation that surrounds medical marijuana.
Results from the randomized phase 3 POLO trial are in, and the quality of life data shows promise for patients with metastatic pancreatic cancer who harbor a germline BRCA gene mutation.
In order to give life to a strategy, a nurse leader must understand the clinical environment and how patients and staff respond to various interventions.
Dennise Geiger, RN, Regional Cancer Care Associates, Central Jersey Division, discusses difficulties nurses face when using telephone triage, and the plan that was developed to better streamline the process.
Jennifer Klemp, PhD, MPH, discusses the importance of measuring outcomes in survivorship care for patients with cancer.
Gwen Wyatt, PhD, RN, FAAN,discusses the challenges associated with conducting a multisite randomized clinical trial.
Rudolph Navari, MD, PhD, professor of Medicine at Indiana University School of Medicine -South Bend, discusses traditional antiemetic treatment for chemotherapy-induced nausea and vomiting (CINV).
A phase III study found that adding 2 years of ovarian function suppression to tamoxifen extended disease-free survival in certain patients with hormone receptor-positive breast cancer.
Joni Watson, MBA, MSN, RN, OCN, Director, Baylor Scott & White Cancer Center, discusses the opportunities Twitter can provide for oncology nurses.
Using mobile apps and other new technologies, clinicians can better monitor and help their patients.
Researchers conducted interviews of patients’ decision-makers to determine how well their understanding of a patient’s prognosis aligned with the physician’s prognostic estimate. The patients were receiving care in the intensive care unit and were identified by physicians as having a high risk of death.
Marie Wood, MD, medical oncologist, University of Vermont, discusses the correlation between aspirin use and lower breast density.
Collaboration to feature content from one of nation’s leading nursing school programs.
There is a growing buzzword in the medical industry, and it is oncology rehabilitation.
Men tend not to seek help for psychosocial issues and notably less often than women do.
Jim Kelly, NFL Hall of Famer, discusses how nurses inspire him.
Chemotherapy-induced cardiotoxicity is defined as a poisonous or detrimental effect upon the heart that can delay cancer treatment, decrease survival, and increase morbidity.
Jason Luke, MD, assistant professor at the University of Chicago Medicine, discusses what he hopes the future of advanced melanoma treatment will look like.
A recent study has found that there may be no risk of increasing skin irritation by using antiperspirants for patients with breast cancer undergoing radiation.
Angie Meillier, RN, MS, CPPM, of Allina Health System, explains why nurses should be sure that patients are ready to hear and understand specific information.
Dr. Harold P. Freeman from Ralph Lauren Center for Cancer Care and Prevention Describes Patient Navigation
Dr. Brian I. Rini from the Taussig Cancer Institute Describes Axitinib's and Sorafenib's Side Effects